NEW YORK – Invitae today announced a partnership with BioMarin Pharmaceuticals on a program to expand access to genetic testing for skeletal dysplasias.
The companies have launched Discover Dysplasias to offer genetic testing at no charge to patients who show signs or symptoms of having a skeletal dysplasia. These rare, mostly genetic disorders, of which there are hundreds of types, affect bones and joints.